Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (331-340 of 469) with videos related to

Pageof 47
Sort By:
Urologic Oncology|February 12, 2021
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, et al.
The Journal of Liquid Biopsy|March 3, 2025
ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patientsAtul Bharde, Snigdha Nadagouda, Manoj Dongare, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III studyCesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Indian Journal of Cancer|August 8, 2018
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaAmit Joshi, Amitesh Anand, Kumar Prabhash, et al.
South Asian Journal of Cancer|February 7, 2018
Oncology Gold Standard<sup>®</sup> practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neckGovind Babu, Ankur Bahl, G S Bhattacharya, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Journal of Geriatric Oncology|February 16, 2025
Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in IndiaVanita Noronha, Jatin Choudhary, Anant Ramaswamy, et al.
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancerAbhishek Mahajan, Gurukrishna B, Shweta Wadhwa, et al.
Pageof 47

Showing results (331-340 of 469) with videos related to

Sort By:
Pageof 47
Urologic Oncology|February 12, 2021
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, et al.
The Journal of Liquid Biopsy|March 3, 2025
ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patientsAtul Bharde, Snigdha Nadagouda, Manoj Dongare, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III studyCesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Indian Journal of Cancer|August 8, 2018
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaAmit Joshi, Amitesh Anand, Kumar Prabhash, et al.
South Asian Journal of Cancer|February 7, 2018
Oncology Gold Standard<sup>®</sup> practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neckGovind Babu, Ankur Bahl, G S Bhattacharya, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Journal of Geriatric Oncology|February 16, 2025
Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in IndiaVanita Noronha, Jatin Choudhary, Anant Ramaswamy, et al.
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancerAbhishek Mahajan, Gurukrishna B, Shweta Wadhwa, et al.
Pageof 47